Digiceuticals Market Share

North America Market Forecast

By 2036, North America region is expected to hold more than 31% digiceuticals market share. The market growth in the region is also expected on account of the rising prevalence of chronic diseases, the rising adoption of digital health technologies, the increasing investments by venture capitalists in healthcare innovation, and the growing acceptance of digital therapeutics by healthcare professionals.

Moreover, the Food and Drug Administration has approved a growing number of digiceuticals, as treatments that doctors can prescribe. This also enables these treatments to be covered by health plans. An example of an FDA approved app is reSET O which offers therapy sessions for individuals struggling with opioid addiction. These sessions are conducted under clinician supervision. ReSET O is currently used in substance abuse facilities throughout the country.

APAC Market Analysis

By 2036, Asia Pacific region in digiceuticals market is anticipated to capture over 27% revenue share. Rising prevalence of lifestyle-related diseases, growing awareness about the importance of preventive healthcare, and increasing government initiatives to promote the use of digital health solutions are the main factors driving the growth of the Asia Pacific market.

For instance, in May 2020 the National Health Commission (NHC) of the People's Republic of China urged governments to create their own online regulatory systems. These platforms would monitor and supervise online healthcare providers as well as expedite the entry of internet-based hospitals into the digiceuticals market.